UK scientists look to repurpose existing antiviral drugs for COVID

UK scientists look to repurpose existing antiviral drugs for COVID British researchers want to repurpose existing antiviral therapies to treat COVID-19, the University of Oxford said on Friday, in an attempt to sidestep lengthy development processes through readily available drugs. Reuters Reuters

Feb 4 (Reuters) - British researchers want to repurpose existing antiviral therapies to treat COVID-19, the University of Oxford said on Friday, in an attempt to sidestep lengthy development processes through readily available drugs.

Scientists will initially screen 138 drugs with known antiviral activity against the COVID-causing SARS-CoV-2 virus to study and identify potent combinations, the university said in a statement on Friday...